- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04077398
Volume vs Concentration: Quadratus Lumborum Blocks With High Volume/Low Concentration or Low Volume/ High Concentration in Nephrectomies
February 12, 2021 updated by: Bruce Ben-David
Volume Versus Concentration: a Prospective, Double Blind, Parallel Study to Compare the Clinical Effectiveness of Bilateral Quadratus Lumborum Blocks Using High Volume/Low Concentration or Low Volume/ High Concentration Local Anesthetic in Nephrectomies
The quadratus lumborum has since 2016 become standard of care for abdominal and retroperitoneal surgeries at UPMC-Shadyside Hospital, replacing paravertebral blocks, and as part of a broader multimodal analgesia institutional Enhanced Recovery After surgery protocol.
Since the first description of this technique, several approaches to and anatomic targets within the quadratus lumborum plane have been described although their mechanism of action, spread, and relative clinical effectiveness remain areas of some debate.
What is proposed here is to investigate the relative clinical effectiveness of the relationship high volume/low concentration of local anesthetic or low volume/ high concentration of local anesthetic.
Study Overview
Status
Withdrawn
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, United States, 15213
- UPMC Shadyside Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients 18-90 years old
- Patients undergoing nephrectomy
- Body Mass Index 19-36
- Male and Female
- All races
- American Society of Anesthesiologist scale I, II, III
Exclusion Criteria:
- Patient refusal
- Pregnancy
- Non-English speaking or inability to participate in the study
- Patients with coagulopathy or With International Normalized Ratio >1,5 the day of the surgery.
- Chronic steroid use
- Chronic pain
- Chronic opiate use
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: low volume High concentration group
1.Low Volume: 30 subjects randomized to Low Volume will receive bilateral Quadratus lumborum Block II.
Each block of 0,75% ropivacaine x 15 mL + dexmedetomidine 0.4 mcg/kg (max dose 30 mcg for age <70, max dose 20 mcg for age >70) + dexamethasone 4 mg
|
There will be two groups, in order to compare two different sets of volumes with the same amount of drug.
we will try to identify if it is better one volume over the other in terms of pain control and consume of opioids, as well the presence or absence of motor weakness.
|
|
Experimental: high volume low concentration
2.High Volume: 30 subjects randomized to High Volume will receive bilateral Quadratus lumborum Block II.
Each block of 0,375% ropivacaine x 30 mL + dexmedetomidine 0.4 mcg/kg (max dose 30 mcg for age <70, max dose 20 mcg for age >70) + dexamethasone 4 mg
|
There will be two groups, in order to compare two different sets of volumes with the same amount of drug.
we will try to identify if it is better one volume over the other in terms of pain control and consume of opioids, as well the presence or absence of motor weakness.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
pain control over the next 72 hours after surgery: Visual analogue scale
Time Frame: 72 hours
|
Visual analogue scale (0-10) measurement
|
72 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
opioid consumption during the first 72 hours
Time Frame: 72 hours
|
opioid consumption in morphine milliequivalents during the first 72 hours
|
72 hours
|
|
time of the first opioid consumption after surgery
Time Frame: 24 hours
|
time after surgery that patient takes to require opioid medication after surgery
|
24 hours
|
|
100 feet walking
Time Frame: 48 hours
|
time after surgery that the patient takes in order to be able to walk 100 feet
|
48 hours
|
|
presence or absence of muscular weakness after Quadratus lumborum type 2 block
Time Frame: 24 hours
|
muscular weakness is associated sometime with femoral quadratus muscle weakness
|
24 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 22, 2020
Primary Completion (Anticipated)
January 1, 2021
Study Completion (Anticipated)
August 1, 2021
Study Registration Dates
First Submitted
August 30, 2019
First Submitted That Met QC Criteria
September 3, 2019
First Posted (Actual)
September 4, 2019
Study Record Updates
Last Update Posted (Actual)
February 16, 2021
Last Update Submitted That Met QC Criteria
February 12, 2021
Last Verified
February 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY19070444
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
there is no plan to share individual participant data.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Yes
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postoperative Pain
-
National and Kapodistrian University of AthensCompletedPostoperative Pain, Acute | Postoperative Pain, Chronic | Postoperative Pain After Thoracic SurgeryGreece
-
Second Affiliated Hospital, School of Medicine,...Not yet recruitingPostoperative Pain | Postoperative Pain Management | Postoperative Pain in Orthopaedics
-
Dr. Negrin University HospitalCompletedPostoperative Pain, Acute | Postoperative Pain, ChronicSpain
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Postoperative Pain, Acute | Postoperative Pain, Chronic | VATSTurkey
-
Aydin Adnan Menderes UniversityCompleted
-
Aydin Adnan Menderes UniversityCompletedAcute Postoperative Pain | Chronic Postoperative PainTurkey
-
Children's National Research InstituteVentureWellRecruitingPostoperative Pain | Acute Pain | Acute Pain, PostoperativeUnited States
-
University of MalayaActive, not recruitingPostoperative Pain | Postoperative Pain ManagementMalaysia
-
Maimonides Medical CenterCompletedPOSTOPERATIVE PAINUnited States
-
University Hospital, AntwerpUnknown
Clinical Trials on Ropivacaine 0.5% Injectable Solution
-
Poznan University of Medical SciencesRecruitingHip Pain Chronic | Hip Osteoarthritis | Hip ArthropathyPoland
-
Rutgers, The State University of New JerseyRecruiting
-
University Hospital, LilleCompleted
-
Centre Hospitalier Universitaire VaudoisCompletedPostoperative Pain | Knee OsteoarthritisSwitzerland
-
Centre hospitalier de l'Université de Montréal...CompletedPostoperative Pain | Total Hip Replacement SurgeryCanada
-
University of MiamiNot yet recruiting
-
Rothman Institute OrthopaedicsEnrolling by invitationFoot Surgery | Ankle Surgery | Popliteal Nerve BlockUnited States
-
Taiwan Liposome CompanyCompletedInguinal HerniaUnited States
-
Saint George HospitalCompleted
-
Singapore General HospitalRecruiting